Turn Therapeutics Inc. (TTRX) stock

TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30

$9.35−0.79 (-7.75%)

Close on Nov 13, 2026Market cap $278.37MP/E –Yield –

Turn Therapeutics statistics

57 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 30, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $278.37M; $272.32M
Enterprise Value: $275.12M; $146.23M
PB Ratio: 48.90; 2.00
P/TBV Ratio: 58.24; 2.22

Share statisticsIndustry

Shares Outstanding: 30M; 58M
Shares Change (YoY): 7.74%; 10.8%
Shares Change (QoQ): 2.50%; 0.50%
Float: 14M; 49M
Shares Held by Insiders: 54.2%; 11.7%
Shares Held by Institutions: 3.88%; 56.4%

Short sellingIndustry

Short Interest: 530,526; –
Short Interest Change: 23.0%; -0.80%
Short % of Float: 3.89%; 9.01%
Short % of Shares Outstanding: 1.78%; 6.30%
Days to Cover: 5.87; 5.15

Stock price statisticsIndustry

52-Week High: $16.45; –
52-Week Low: $2.57; –
20-Day Moving Average: $10.11; –
50-Day Moving Average: $11.72; –
200-Day Moving Average: $7.25; –
Average True Range (14): $1.00; –
Price Change (1 Week): -1.42%; -1.15%
Price Change (1 Month): -19.4%; -4.87%
Price Change (3 Months): -5.70%; -21.0%
Price Change (6 Months): 130.7%; -20.6%
Price Change (YTD): 137.2%; -23.6%
Price Change (1 Year): 112.4%; -22.4%
Average Volume (10 Days): 100,129; –
Average Volume (20 Days): 95,531; –
Average Volume (90 Days): 105,490; –
Relative Volume: 0.86; 0.70
Relative Strength Index (14): 41.2; 43.4
Volatility (1 Year): 99.3%; 80.1%

Returns on capitalIndustry

Return on Equity (ROE): -412.3%; -49.9%
Return on Assets (ROA): -123.7%; -40.6%
Return on Capital Employed (ROCE): -54.8%; -37.9%

Financial positionIndustry

Current Ratio: 3.19; 3.30
Quick Ratio: 2.71; 2.39
Debt / Equity: 1.09; 0.49

EfficiencyIndustry

Profits Per Employee: -$6.39M; -$689.41K
Employee Count: 2; 74

Income statement (TTM)Industry

Operating Income: -$7.05M; -$21.37M
Net Income: -$12.77M; -$22.35M
EBITDA: -$7.05M; -$17.21M
EPS (Diluted): -$0.43; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $9.43M; $68.68M
Total Debt: $6.19M; $116.91M
Net Cash (Debt): $3.25M; $17.76M
Net Cash Per Share: $0.11; $0.80
Equity (Book Value): $5.69M; $53.89M
Book Value Per Share: $0.19; $1.50
Tangible Book Value: $4.78M; $27.13M
Working Capital: $7.60M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$5.28M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -4.59%; -21.8%

Scores and fair valueIndustry

Altman Z-Score: 11.77; 0.23
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	TTRX	S&P 500	Difference	TTRX per year	S&P 500 per year
1 month	-11.8%	-3.0%	−8.8 pts
3 months	-5.2%	-2.8%	−2.4 pts
Year to date	+137.2%	+11.5%	+125.7 pts
1 year	+128.5%	+13.5%	+115.0 pts
3 years	+46625.0%	+77.7%	+46547.3 pts	+676.0%	+21.1%
5 years	+46625.0%	+72.6%	+46552.4 pts	+241.9%	+11.5%
10 years	+46625.0%	+308.2%	+46316.8 pts	+84.9%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M TTRX shares were sold short on Oct 30, 2026, up 23.0% from the previous report, or 3.89% of the shares available to trade. At recent volumes it would take 5.9 days to buy them back. Over the last 20 sessions, 61.9% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	530,526	+23.0%	90,436	5.9
Oct 15, 2026	431,200	+60.4%	101,360	4.3
Sep 30, 2026	268,757	+74.1%	201,829	1.3
Sep 15, 2026	154,372	+16.3%	135,386	1.1
Aug 31, 2026	132,779	+15.6%	41,383	3.2
Aug 14, 2026	114,828	+36.2%	58,949	1.9
Jul 31, 2026	84,329	+46.1%	90,456	1.0
Jul 15, 2026	57,729	+49.9%	167,824	1.0
Jun 30, 2026	38,506	+25.5%	41,675	1.0
Jun 15, 2026	30,684	-51.9%	72,651	1.0
May 29, 2026	63,729	-1.4%	65,133	1.0
May 15, 2026	64,613	+25.7%	22,950	2.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?